Skip to main content
editorial
. 2020 Apr-Jun;16(2):216–222. doi: 10.4183/aeb.2020.216

Table 4.

Frequency of sarcopenia determined by the Romanian SARC-F, two EWGSOP2 definitions, muscle mass, strength and performance

Men Women Total
Sarcopenia No sarcopenia Sarcopenia No sarcopenia Sarcopenia No sarcopenia
N % N % N % N % N % N %
Sarcopenia / EWGSOP2
 Sarc-F < 4 4 21.05 15 78.95 3 10.34 26 89.66 7 14.59 41 85.42
 Sarc-F ≥ 4 5 83.33 1 16.67 8 30.77 18 69.23 13 40.62 19 59.38
Probable Sarcopenia / EWGSOP2
 Sarc-F < 4 5 26.32 14 73.68 6 20.69 23 79.31 11 22.92 37 77.08
 Sarc-F ≥ 4 5 83.33 1 16.67 20 76.92 6 23.08 25 78.12 7 21.88
Muscle mass and strength
 BIA 13 54.17 11 45.83 13 23.64 42 76.36 26 32.91 53 67.09
 HGS 9 50 9 50 20 40.82 29 59.18 29 43.28 38 56.72
Muscle performance
 CS 3 20 12 80 11 26.19 31 73.81 14 24.56 43 75.44
 GS 6 40 9 60 25 58.14 18 41.86 31 53.45 27 46.55